Literature DB >> 26272329

Phytochemical and Botanical Therapies for Rosacea: A Systematic Review.

Whitney A Fisk1, Hadar A Lev-Tov2, Ashley K Clark3, Raja K Sivamani1.   

Abstract

Botanical and cosmeceutical therapies are commonly used to treat symptoms of rosacea such as facial erythema, papules/pustule counts, and telangiectasia. These products may contain plant extracts, phytochemicals, and herbal formulations. The objective of this study was to review clinical studies evaluating the use of botanical agents for the treatment of rosacea. MEDLINE and Embase databases were searched for clinical studies evaluating botanical therapies for rosacea. Major results were summarized, and study methodology was analyzed. Several botanical therapies may be promising for rosacea symptoms, but few studies are methodologically rigorous. Several plant extract and phytochemicals effectively improved facial erythema and papule/pustule counts caused by rosacea. Many studies are not methodologically rigorous. Further research is critical, as many botanicals have been evaluated in only one study. Botanical agents may reduce facial erythema and effectively improve papule/pustule counts associated with rosacea. Although promising, further research in the area is imperative.
Copyright © 2015 John Wiley & Sons, Ltd.

Entities:  

Keywords:  ROSACEA; alternative; botanical; herbs; phytochemical; plants

Mesh:

Substances:

Year:  2015        PMID: 26272329     DOI: 10.1002/ptr.5432

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  3 in total

Review 1.  Sandalwood Album Oil as a Botanical Therapeutic in Dermatology.

Authors:  Ronald L Moy; Corey Levenson
Journal:  J Clin Aesthet Dermatol       Date:  2017-10-01

Review 2.  Current application of phytocompound-based nanocosmeceuticals for beauty and skin therapy.

Authors:  Palanivel Ganesan; Dong-Kug Choi
Journal:  Int J Nanomedicine       Date:  2016-05-11

3.  Cinnamtannin B1 attenuates rosacea-like signs via inhibition of pro-inflammatory cytokine production and down-regulation of the MAPK pathway.

Authors:  Hung-Lin Kan; Chia-Chi Wang; Yin-Hua Cheng; Chi-Lung Yang; Hsun-Shuo Chang; Ih-Sheng Chen; Ying-Chi Lin
Journal:  PeerJ       Date:  2020-12-21       Impact factor: 2.984

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.